Has Ray Vaughters, MD received payments from drug or device companies?

Yes. Drug and device makers reported $321,058 in general payments to Ray Vaughters, MD across 1,134 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Ray Vaughters, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Ray Vaughters, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Ray Vaughters, MD

Endocrinology, Diabetes & Metabolism · Aiken, SCNPI 1457327587

Payments from drug & device makers

$321,058in general payments, 2019–2025

Across 1,134 payments — averaging $283.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Lilly USA, LLC$109K
Novo Nordisk$96K
AstraZeneca$71K
Mannkind Corporation$34K
Sanofi-aventis U.S. LLC$1K
Amgen$1K
plus $7K from 49 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Lilly USA, LLC	277	$109,189
Novo Nordisk	167	$96,195
AstraZeneca	141	$71,414
Mannkind Corporation	92	$34,372
Sanofi-aventis U.S. LLC	26	$1,396
Amgen(2 entities)	72	$1,276
Corcept Therapeutics	38	$999
Xeris Pharmaceuticals, Inc.	35	$766
Dexcom, Inc.	40	$705
Amarin Pharma, Inc.	33	$541
Antares Pharma, Inc.	36	$488
BETA Bionics, Inc.	13	$371
Radius Health, Inc.	13	$276
Insulet Corporation	12	$268
Esperion Therapeutics, Inc.	8	$257
Medtronic(2 entities)	11	$256
Boehringer Ingelheim	15	$255
Merck	15	$198
Novartis	10	$193
Bayer	7	$150
Cequr Corporation	2	$149
Senseonics, Incorporated	3	$104
Recordati_rare_diseases_inc.	4	$102
Ascendis Pharma Endocrinology Inc	5	$100
Vivus LLC	5	$71
Madrigal Pharmaceuticals	2	$65
IBSA Pharma Inc.	4	$63
BD	3	$56
Globus Medical	1	$51
Lifescan, Inc.	3	$50
Johnson & Johnson	3	$50
AbbVie	3	$49
Ultragenyx Pharmaceutical Inc.	2	$46
Eisai Inc.	2	$40
Acerus Pharmaceuticals Corporation	2	$37
Renalytix AI, Inc.	2	$35
Endo Pharmaceuticals Inc.	2	$33
Zealand Pharma US, Inc.	2	$32
Nevro Corp.	1	$31
Tolmar, Inc.	2	$30
Halozyme Inc	2	$27
Amneal Pharmaceuticals LLC	2	$27
Boston Scientific	1	$25
Clarus Therapeutics Inc.	3	$23
Currax Pharmaceuticals LLC	2	$23
Neurocrine Biosciences, Inc.	1	$22
Shire North American Group Inc	1	$22
Abbott	1	$19
Vifor Pharma, Inc.	1	$18
Sequel Med Tech, LLC	1	$18
Inari Medical, Inc.	1	$17
Azurity Pharmaceuticals, Inc.	1	$16
Vistapharm, Inc.	1	$15
Amryt Pharma Holdings Ltd	1	$14
Kowa Pharmaceuticals America, Inc.	1	$13

How this compares

$321,058 in reported general payments places this provider in the 90th percentile of 99 endocrinology, diabetes & metabolism providers in South Carolina.

See all endocrinology, diabetes & metabolism providers in South Carolina →

Medicare billing

Part B allowed, 2024

$386,603

Medicare patients

787

Services billed

6,844

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other endocrinology, diabetes & metabolism in Aiken

Ronald MayfieldSpartanburg$8.9M
Donald EagertonMyrtle Beach$7.9M
Beatrice HullCharleston$987K
Anne LarochelleMyrtle Beach$678K
Gauri DhirMyrtle Beach$417K
Cory WhiteGreenville$413K
Louis HaenelCharleston$377K
Vonda CalcuttWalterboro$368K
Kathie HermayerCharleston$337K
Joseph MathewsSummerville$297K

See the full list for South Carolina →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →